ELISABETH THROOP: Open Payments
NPI 1770219461 · MARENGO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$370 in 21 payments from 7 companies in 2025. Trend: 2023 $80 · 2024 $508 · 2025 $370
Food & beverage: $370
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $170 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $94 |
| Exact Sciences Corporation | 2 | $38 |
| Biogen, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $13 |
Products named: VRAYLAR, CAPLYTA, MAVYRET, The Cologuard Plus Collection Kit, ZURZUVAE, PAXLOVID, Cologuard Collection Kit, TRELEGY ELLIPTA.
Industry payments across IN — which companies pay providers there.
